• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fractyl Health, Inc. - Common Stock (NQ:GUTS)

0.7067 -0.0014 (-0.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Fractyl Health, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Fractyl Health, Inc. (GUTS)
Today 9:02 EDT
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers – GUTS
September 01, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Deadline Approaching: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
September 01, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Deadline Alert: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
September 01, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Deadline Soon: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
August 31, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2026 in Fractyl Health, Inc. Lawsuit - GUTS
August 28, 2026
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Law Offices of Howard G. Smith Encourages Fractyl Health, Inc. (GUTS) Shareholders To Inquire About Securities Fraud Class Action
August 27, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Law Offices of Frank R. Cruz Encourages Fractyl Health, Inc. (GUTS) Shareholders to Inquire About Securities Fraud Class Action
August 26, 2026
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Securities Fraud Investigation Into Fractyl Health, Inc. (GUTS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
August 26, 2026
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Faruqi & Faruqi, LLP Urges Fractyl Health, Inc. (NASDAQ: GUTS) Investors to Seek Counsel Before the October 20, 2026 Lead Plaintiff Deadline in the Securities Class Action
August 26, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
August 26, 2026
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Fractyl Health, Inc. (GUTS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
August 25, 2026
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Stockholder Alert: Robbins LLP Informs Investors of the Fractyl Health, Inc. Class Action
August 21, 2026
From Robbins LLP
Via Business Wire
News headline image
Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance
August 20, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates
August 10, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026
August 03, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health to Participate in Upcoming Investor Events
July 22, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation
July 15, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure
June 04, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy
June 01, 2026
Experienced market access leader joins to build reimbursement and health economic infrastructure for Revita® ahead of anticipated REMAIN-1 Pivotal Cohort topline data in early Q4 2026 
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates
May 12, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes
May 11, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference
May 05, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
March 24, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026
March 17, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance
February 26, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – GUTS
January 30, 2026
From DJS Law Group
Via Business Wire
News headline image
Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – GUTS
January 29, 2026
From The DJS Law Group
Via Business Wire
News headline image
Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation
January 29, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
News headline image
Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness
January 06, 2026
From Fractyl Health, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap